DNA Sequencing Market Analysis

Technology (Next Generation Sequencing, Third Generation Sequencing, Sanger Sequencing)

The next-generation sequencing segment in the DNA sequencing market is expected to account for the largest revenue share of 66.2% during the forecast period. NGS significantly lowers the cost of sequencing and can yield comprehensive and accurate results quickly. The demand for this segment is significantly high since millions of DNA fragments can undergo simultaneous analysis using NGS sequencing. In recent trends, NGS sequencing costs are continuing to decline, improving accessibility and scope of investments. For instance, in 2022, the American Society for Microbiology (ASM) was awarded funding from the Centers for Disease Control and Prevention (CDC) to offer advanced training on NGS.

Other factors playing a role in this segment’s market growth are the new product launches by the market players. For instance, Qiagen Digital Insights released QIAGEN CLC Genomics Workbench Premium in January 2023, which improves the speed for whole genome sequencing (WGS). With rising technological advancements to increase accuracy, the ability to read longer DNA stretches, and develop personalized medicines, this segment is poised to grow at a rapid rate.

Product (Consumables, Instrument, Services)

The consumables segment in the DNA sequencing market accounted for a significant revenue share in 2023. A large number of consumable goods i.e. sequencing consumables, are required during sequencing. Sequencing consumables are required in different stages of a DNA sequencing workflow. Some sequencing consumables are reagents including nucleotides and dye terminators, and kits such as sample preparation kits, and library preparation kits. The demand for consumables has increased due to the continuous advancement in DNA sequencing methods. The growth of this segment is expected to rise during the forecast period due to the increasing use of genomics in healthcare and research.

Our in-depth analysis of the DNA sequencing market includes the following segments:

Technology	Next Generation Sequencing Third Generation Sequencing Sanger Sequencing
Product	Consumables Instruments Services
Application	Clinical Application Oncology Forensics & Agrigenomics HLA Typing Reproductive Health Others
End use	Academic Research Clinical Research Hospitals Clinics Biotechnology & Pharmaceutical Companies Others

Frequently Asked Questions (FAQ)

In 2024, the DNA sequencing industry is valued at USD 12.9 billion.

The market size for DNA sequencing is poised to cross USD 69.7 billion by the end of 2037. The market is expected to expand at a CAGR of 15.1% during the forecast period i.e., between 2025-2037. In 2024, the DNA sequencing market is valued at USD 12.9 billion.

The leading players in the market are Illumina, Inc., Myriad Genetics, Thermo Fisher Scientific, PerkinElmer Inc., Eurofins Scientific, Nippon Genetics and others.

The next generation sequencing (NGS) segment in technology will hold the largest market share for DNA sequencing during the forecast period i.e., 2025-2037. The segment is poised to grow at a rapid rate and register significant revenue CAGR owing to the low cost of NGS sequencing and the accuracy of results.

The North America market share is poised to be the largest with a revenue share of 51.5% by the end of 2037. The key drivers in North America are robust research infrastructure, high number of investments in research, and significant product launches.

DNA Sequencing Market Analysis